System Transmission

Top Signal

100#1 JOB

Activity

2192Ripe

+952 today

System

Livenow

Terminal Asset View

stockNASDAQ

ZYME

$22.88-1.51%

Zymeworks BC Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

31Neutral

Live Analysis Active

Company Mission

Zymeworks creates specialized antibody-based medicines designed to fight cancer more effectively. They use advanced engineering technology to develop these treatments, which are then tested in clinical trials. The company makes money by partnering with larger pharmaceutical companies who help develop and market their drugs, and they could earn royalties if any treatments get approved and sold to patients.

ZYM

Industry Context

The biotechnology industry focuses on developing treatments using biological systems. Companies in this space research new drugs, particularly for complex diseases like cancer, and often partner with larger pharmaceutical firms to bring treatments to market. The sector experiences cycles of investor interest based on clinical trial results and regulatory approvals.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

74Matrix

Market Momentum

43.9— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.0x— Normal Volume

Today's Change

-1.51%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ZYME across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 12:58 AM UTC

As-of 03-15-2026 00:43 UTC

Develops antibody-based cancer drugs and makes money by licensing these treatments to pharmaceutical companies and receiving milestone payments.

Technical squeeze detected as price compresses near key levels, suggesting potential breakout movement when volatility expands.

Biotech sector showing renewed interest in targeted cancer therapies, which could benefit companies with advanced antibody platforms like Zymeworks.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...